A BILL 
To amend title XI of the Social Security Act to provide 
greater transparency of discounts provided by drug man-
ufacturers. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Public Disclosure of 
4
Drug Discounts Act’’. 
5
SEC. 2. PUBLIC DISCLOSURE OF DRUG DISCOUNTS. 
6
Section 1150A of the Social Security Act (42 U.S.C. 
7
1320b–23) is amended— 
8
21:52 Apr 17, 2019
H2115
2 
•HR 2115 IH
(1) in subsection (c), in the matter preceding 
1
paragraph (1), by inserting ‘‘(other than as per-
2
mitted under subsection (e))’’ after ‘‘disclosed by the 
3
Secretary’’; and 
4
(2) by adding at the end the following new sub-
5
section: 
6
‘‘(e) PUBLIC AVAILABILITY OF CERTAIN INFORMA-
7
TION.— 
8
‘‘(1) IN GENERAL.—In order to allow the com-
9
parison of PBMs’ ability to negotiate rebates, dis-
10
counts, and price concessions and the amount of 
11
such rebates, discounts, and price concessions that 
12
are passed through to plan sponsors, beginning Jan-
13
uary 1, 2020, the Secretary shall make available on 
14
the Internet website of the Department of Health 
15
and Human Services the information with respect to 
16
the second preceding calendar year provided to the 
17
Secretary on generic dispensing rates (as described 
18
in paragraph (1) of subsection (b)) and information 
19
provided to the Secretary under paragraphs (2) and 
20
(3) of such subsection that, as determined by the 
21
Secretary, is with respect to each PBM. 
22
‘‘(2) AVAILABILITY OF DATA.—In carrying out 
23
paragraph (1), the Secretary shall ensure the fol-
24
lowing: 
25
21:52 Apr 17, 2019
H2115
3 
•HR 2115 IH
‘‘(A) CONFIDENTIALITY.—The information 
1
described in such paragraph is displayed in a 
2
manner that prevents the disclosure of informa-
3
tion on rebates, discounts, and price conces-
4
sions, with respect to an individual drug or an 
5
individual plan. 
6
‘‘(B) CLASS OF DRUG.—The information 
7
described in such paragraph is made available 
8
by class of drug, using an existing classification 
9
system, but only if the class contains such num-
10
ber of drugs, as specified by the Secretary, to 
11
ensure confidentiality of proprietary informa-
12
tion or other information that is prevented to 
13
be disclosed under subparagraph (A).’’. 
14
Æ 
21:52 Apr 17, 2019
H2115
